TOT BIOPHARM INTERNATIONAL COMPANY LIMITED

Altre lingue TOT BIOPHARM International Company Limited

Azioni

1875

HK0000545266

Mercato chiuso - Hong Kong S.E. Altri mercati azionari 10:09:00 03/05/2024			Variaz. 5gg	Var. 1 gen.
1,85 ^HKD	+6,32%		+10,12%	-6,09%

15/03	TOT BIOPHARM International Company Limited riporta i risultati degli utili per l'intero anno conclusosi il 31 dicembre 2023	CI
2023	La perdita di TOT Biopharm si riduce nel primo semestre	MT

Altre lingue

Sblocca tutte le notizie su tutte le aziende: non perdere mai più un'opportunità di investimento redditizia!

Registrazione 100% gratuita

TOT BIOPHARM International Company Limited Reports Earnings Results for the Full Year Ended December 31, 2023	15/03
TOT Biopharm's Loss Narrows in January-September Period	10/11
TOT Biopharm's Loss Narrows in H1	14/08/23
TOT BIOPHARM International Company Limited Announces Directorate and Committee Changes	11/08/23
TOT BIOPHARM International Company Limited Reports Earnings Results for the Half Year Ended June 30, 2023	11/08/23
TOT BIOPHARM's Q1 Loss Widens Despite Higher Revenue	12/05/23
TOT BIOPHARM International Company Limited Reports Earnings Results for the Full Year Ended December 31, 2022	23/03/23
TOT Biopharm Terminates Phase 3 Trial of Breast Cancer Drug; Shares Fall 5%	20/03/23
TOT BIOPHARM International Company Limited Announces Termination of Phase III Clinical Trial Study and Development of Taa013	17/03/23
TOT BIOPHARM’s Production Base for Antibody Drug Receives Good Manufacturing Report from Europe	26/10/22
TOT BIOPHARM International Company Limited Announces Change of Address of Registered Office	15/08/22
TOT Biopharm International Logs Reduction in H1 Net Loss; Shares Climb 3%	15/08/22
TOT BIOPHARM International Company Limited Reports Earnings Results for the Half Year Ended June 30, 2022	12/08/22
Connected Transactions Involving Subscription by Vivo Suzhou Fund and Centerlab for TOP BIOPHARM Shares	01/06/22
TOT BIOPHARM International Company Limited announced that it expects to receive HKD 110 million in funding from Center Laboratories, Inc.	31/05/22
TOT Biopharm Narrows Loss on Lower Selling, R&D Expenses in 2021	25/03/22
TOT BIOPHARM International Company Limited Reports Earnings Results for the Full Year Ended December 31, 2021	24/03/22
TOT BIOPHARM International Company Limited Announces Change of Directors and Change of Composition of Board Committees	13/03/22
China Approves New Indications for TOT Biopharm's Cancer Drug	10/03/22
TOT BIOPHARM International Company Limited Announces Change of Joint Company Secretary and Finance Personnel	31/01/22

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue TOT BIOPHARM International Company Limited

Azioni

1875

HK0000545266

Altre lingue

Filtri